학술논문
A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: ACCORD-2
Document Type
Article
Author
Wilkinson, T.; De Soyza, A.; Carroll, M.; Chalmers, J.D.; Crooks, M.G.; Griffiths, G.; Shankar-Hari, M.; Ho, L.-P.; Horsley, A.; Woodcock, A.; Singh, D.; Kell, C.; Lara, B.; Mishra, B.; Moate, R.; Page, C.; Pandya, H.; Reid, F.; Raw, J.; Saralaya, D.; Scott, I.C.; Siddiqui, S.; Ustianowski, A.; van Zuydam, N.
Source
In: ERJ Open Research . (ERJ Open Research, September 2023, 9(5))
Subject
Language
English
ISSN
23120541